January is officially Cervical Health Awareness Month. At myLAB Box, we want to do our part to spread the word and help stem the quickly growing tide of this disease.
For this reason, we’ve partnered with The National LGBT Cancer Network, The Rural Cancer Prevention Center, and transgender activist Buck Angel. Together, we’re helping more people screen for cervical cancer by offering a discount to customers and donating free At Home STD Tests to our partner organizations for each test purchased. This campaign begins today, January 14th, and runs through February 25th.
Read on for further details:
For Every Four Kits Purchased, myLAB Box and Partners Donate one Free HPV At Home STD Test Kit
The most important thing you can do to help prevent cervical cancer is to have regular screening tests beginning at age 21. Screening tests can prevent cervical cancer or find it early enough to treat and cure.
Cervical cancer screening uses advanced DNA technology to look for the high-risk types of HPV that can cause the disease. myLAB Box’s At Home Cervical Cancer HPV test kit provides you with the option to administer these screenings from the comfort of your own home. The test can accurately report if you are at risk of developing cervical cancer before any cancer cells are even present.
“Cervical Health Awareness Month is a great time to remind everyone what they can do to help prevent and reduce the risk of cervical cancer,” said Lora Ivanova, CEO & Co-Founder, myLAB Box.
This is why myLAB Box is offering 10% off of every At Home HPV test when shoppers use the discount code: fightcancer10.
For every 4 kits purchased with the code, myLAB Box will donate one HPV kit to their cancer prevention partners, The National LGBT Cancer Network and The Rural Cancer Prevention Center. People will also have the option to donate directly to Rural Cancer Prevention Center so they can purchase kits to give away to people who need them.
Joining myLAB Box and these organizations is sex-positive speaker and activist, Buck Angel. Buck empowers his audience through self-acceptance and encourages everyone to be comfortable in their own skin. He has spoken at Yale, Cornell and many other universities. To help spread the word about Cervical Health Awareness Month, Buck is will record a how-to video. This video will include him unboxing a kit. After, Buck will walk participants through the testing process using with a model of a cervix.
Additionally, Buck is also involved with the follow-up to study participants when they get results. He’ll help to connect them to appropriate resources. You can learn more about Buck at his official website.
Cervical Cancer is on the Rise
Cervical cancer is a slow-growing cancer that is caused by the Human Papillomavirus, or HPV. According to the Centers for Disease Control and Prevention, genital HPV is the #1 most common sexually transmitted disease (STD) in the United States. In fact, HPV is so prevalent, that almost half of all American adults are infected. While there are many varieties of genital HPV, only about 14 are considered the high-risk types of HPV that have been linked to cervical cancer.
- It’s estimated that more than 12,000 women in the U.S. are diagnosed with cervical cancer every year.
- About 1 in 20 women who are 30 years of age and over has high-risk HPV. This means that they have an increased risk of developing cervical cancer.
- Women who are 30-and-older and test positive for these high-risk viruses are more likely to have HPV infections. Over time, these persistent HPV infections may cause changes in the cells of the cervix. Without regular screening and treatment, these changes can develop into cervical cancer.
- Bulto GA, Demmissie DB and Daka KB. (2019). Knowledge about Cervical Cancer, Screening Practices and associated factors among Women Living with HIV in Public Hospitals of West Shoa Zone, Central Ethiopia. Journal of Women’s Health Care.
- Jean M. Bouquet, Andrea Chernau, Rachel McLaughlin and Qamrul Choudhury. (2019). A New Vaginal Speculum and an Inexpensive Kit to Screen and Treat Dysplasia and Cancer of the Cervix. Journal of Women’s Health Care.
- P J van Diest, H Holzel. (2002). Cervical cancer. Journal of Clinical Pathology.
- Nainakshi Kashyap, M.Sc Nursing, Nadiya Krishnan, Sukhpal Kaur, and Sandhya Ghai. (2019). Risk Factors of Cervical Cancer: A Case-Control Study. Asia Pac J Oncol Nurs.
- Paul A Cohen, MD Prof Anjua Jhingran, MD Prof Ana Oaknin, MD Prof Lynette Denny, PhD. (2019). Cervical cancer. The Lancet.
- Birgitte Baldur-Felskov, Christian Dehlendorff, Christian Munk, Susanne K. Kjaer. (2014). Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia—Nationwide Follow-up of Young Danish Women. Journal of the National Cancer Institute.
- Seiji Mabuchi, Yuri Matsumoto, Mahiru Kawano, Kazumasa Minami, Yuji Seo, Tomoyuki Sasano, Ryoko Takahashi, Hiromasa Kuroda, Takeshi Hisamatsu, Aiko Kakigano, Masami Hayashi, Kenjiro Sawada, Toshimitsu Hamasaki, Eiichi Morii, Hirohisa Kurachi, Nariaki Matsuura, Tadashi Kimura. (2014). Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant Feature. Journal of the National Cancer Institute.
- Long Fu Xi, Mark Schiffman, Laura A. Koutsky, James P. Hughes, Rachel L. Winer, Constance Mao, Ayaka Hulbert, Shu-Kuang Lee, Zhenping Shen, Nancy B. Kiviat. (2014). Lineages of Oncogenic Human Papillomavirus Types Other Than Type 16 and 18 and Risk for Cervical Intraepithelial Neoplasia. Journal of the National Cancer Institute.